Mythri Raghunandan

Mythri Raghunandan

Patient Enrollment and Retention Challenges in Clinical Trials2 min read

A successful clinical trial depends on effectively enrolling and retaining participants. As the study progresses from Phase 1 to Phase 3 the number of participants required increases.

Research shows that 9 out of 10 trials would not meet enrollment goals in a stipulated time which results in delays in finding new and better medication.

The complexity in trials is another key factor that is responsible for low enrollment rates.

Studies show that only 10 to 27% of patients with Alzheimer’s are eligible for trials. In a study of Alzheimer’s 205 patients with the disease were selected from the database initially. The following were not included based on the specific inclusion and exclusion criteria.

The following are the key challenges that impact patient enrollment and retention.

  1. Lack of awareness
    • 50% of all respondents were not aware of clinical trials.
    • 4% have participated in a trial.
    • 96% have never participated in a trial.
  2. Communication
    • Participants prefer communication and motivation about trials from their immediate care physicians. The physicians are unaware of research possibilities and might hesitate to refer elderly patients to studies. The approval to participate in a trial depends on the advice of the doctor and trust in his practice.
  3. Complex protocol
    • The complexity in trials is another key factor that is responsible for low enrollment rates.
    • Studies show that only 10 to 27% of patients with Alzheimer’s are eligible for trials. In a study of Alzheimer’s 205 patients with the disease were selected from the database initially. The following were not included based on the specific inclusion and exclusion criteria.
    • 57% had abnormalities with MRI
    • 37% were on unauthorized medication
    • 37% lack of study informant
    • 24%presence of non-authorized disease
  4. Long manual procedures
    • Patients are burdened with questionnaires which are lengthy, and they eventually lose interest. Once enrolled they undergo test procedures in many health centers at various intervals based on the study requirements. Patients are unwilling to undergo few procedures like brain imaging and quit due to this.
  5. Treatment risks
    • 52% faced adverse effects in Amitriptyline group
    • 27% under the Placebo group
    • 3% withdrew from the study

The frequent adverse effects reported were drowsiness, constipation and dry mouth.

Cloudbyz is focussed on providing innovative solutions for life science customers. Cloudbyz ClinicalWave solution built 100% native on Salesforce brings all the clinical trial stakeholders together. Patients, as well as the healthy Volunteers, can search for clinical trials pertaining to their therapeutic condition, age, location and other parameters. Interested volunteers can undergo prescreening through phone or website.

Our solution builds awareness and educates the general public and patient population on a clinical trial, process, benefits and risks. Cloudbyz CTMS solution offers real-time visibility on recruitment metrics to enhance patient recruitment and retention.

Mythri Raghunandan

Clinical Research Specialist

Cloudbyz Inc.

Email: mythri.raghunandan@cloudbyz.com

Linkedin: https://www.linkedin.com/in/mythri-raghunandan-578605105/

SHARE THIS POST

LinkedIn
Twitter
Facebook

Related Blog​s

Clinical Research
Abhijit Joshi

Enabling Your Remote Workforce

We thought of changing it up this week to share how our team is working with our customers during these unprecedented times.

With today’s capricious working culture, here are some practices we are implementing with our loyal customers:

Read More »
Clinical Research
Abhijit Joshi

The Clinical Study Protocol: The Basics

If you are new to the clinical research industry, it’s important to know how clinical studies are developed and run. The basis for all such studies is the study protocol, about which this piece will provide a high-level overview.

Read More »
Clinical Research
JeyaMani Maran

How Chatbots Can be Employed in Clinical Trials?

Healthcare industry as a whole is now looking to better engage with patients using bots, where, the patients care aspect is being automated. The impersonal nature of the bots has a benefit in various situations, wherein a real doctor is not needed. In many cases, patients are more transparent to these chatbots than they are…

Read More »

©2020 Cloudbyz Inc. All Rights Reserved.